MINYANVILLE ORIGINAL The three most active funds and stocks in pre-market trading on the Nasdaq (INDEXNASDAQ:.IXIC) were Myrexis
(NASDAQ:MYRX), Gilead Sciences (NASDAQ:GILD),
and Clovis Oncology
(NASDAQ:CLVS) as of 9:15 a.m. EST.
2,098,200 shares of Myrexis, which was up $0.42, or 17.95%.
today that the board of directors of Myrexis have decided to dissolve the biopharmaceutical company. Shareholders will receive approximately between $72.9 million and $77.9 million, or between $2.72 and $2.91 per share.
1,435,288 shares of Gilead Sciences, which was up $7.47, or 11.49%
. According to Bloomberg
, a combination of Gilead's experimental hepatitis C therapies removed the virus in 100% of patients in trial.
Investors also traded
563,272 shares of Clovis Oncology, which was down $8.74, or 40.67%.
Clovis' experimental drug for pancreatic cancer, CP-4126, failed
in a late stage trial. The company has suspended all development of the drug.
No positions in stocks mentioned.